Compare VNRX & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNRX | SCOR |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.2M | 32.8M |
| IPO Year | N/A | 2007 |
| Metric | VNRX | SCOR |
|---|---|---|
| Price | $0.28 | $6.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.17 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 13.6K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,472,007.00 | ★ $358,940,000.00 |
| Revenue This Year | $55.33 | $2.01 |
| Revenue Next Year | $493.79 | $1.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.48 | 0.77 |
| 52 Week Low | $0.27 | $4.39 |
| 52 Week High | $0.94 | $10.18 |
| Indicator | VNRX | SCOR |
|---|---|---|
| Relative Strength Index (RSI) | 32.86 | 49.15 |
| Support Level | $0.28 | $6.60 |
| Resistance Level | $0.34 | $7.15 |
| Average True Range (ATR) | 0.03 | 0.38 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 11.30 | 67.62 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.